Search Results

You are looking at 1 - 10 of 23 items for :

  • hyperprolactinemia x
Clear All
Open access

Anastasia P Athanasoulia-Kaspar, Kathrin H Popp and Gunter Karl Stalla

prolactin, tumor growth or further uncontrolled hyperprolactinemia-related symptoms), clinicians are being confronted with the dilemma of treating patients while having to deal with severe possible side effects. According to the available literature

Open access

Lijin Ji, Na Yi, Qi Zhang, Shuo Zhang, Xiaoxia Liu, Hongli Shi and Bin Lu

diameter of ≥1 cm ( 2 ). Clinical manifestations include hyperprolactinemia and local tumor mass effects. The former can cause amenorrhea, lactation and infertility in females. In males, sexual dysfunction and infertility are the most common deleterious

Open access

Sarah Byberg, Jesper Futtrup, Mikkel Andreassen and Jesper Krogh

diabetes in men ( 11 ). In two large cohort studies hyperprolactinemia was associated with increased incidence of cardiovascular disease and cardiovascular mortality in men only ( 2 , 3 ). However, the association between prolactin and excess disease

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan and Graham P Leese

Kleinberg DL Montori VM Schlechte JA Wass JA. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline . Journal of Clinical Endocrinology and Metabolism 2011 96 273 – 288 . ( doi:10.1210/jc.2010

Open access

Mikkel Andreassen, Anders Juul, Ulla Feldt-Rasmussen and Niels Jørgensen

effect on release of gonadotropins ( 13 , 14 , 15 ). Therefore, results obtained in patients with hyperprolactinemia may not be extrapolated to patients with hypogonadotropic hypogonadism due to other diseases. In the present study, we examined semen

Open access

Adrian F Daly, Liliya Rostomyan, Daniela Betea, Jean-François Bonneville, Chiara Villa, Natalia S Pellegata, Beatrice Waser, Jean-Claude Reubi, Catherine Waeber Stephan, Emanuel Christ and Albert Beckers

/mL; normal range: 85–218), and hyperprolactinemia (739 mIU/L; Fig. 2A ). Other biochemical and hormonal profiles were normal apart from the presence of impaired glucose tolerance. He underwent a transsphenoidal resection of the accessible pituitary tumor

Open access

Shruti Khare, Anurag R Lila, Hiren Patt, Chaitanya Yerawar, Manjunath Goroshi, Tushar Bandgar and Nalini S Shah

:10.1016/j.beem.2009.05.003 ). 2 Colao A Sarno AD Cappabianca P Briganti F Pivonello R Somma CD Faggiano A . Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia . European Journal of

Open access

Vittorio Unfer, Fabio Facchinetti, Beatrice Orrù, Barbara Giordani and John Nestler

 + FA vs FA 12–16 Gerli et al . ( 49 ) Italy DBRCT (№ = 92)Treated: 45Control: 47 3535.2 Age: <35 years, PCOS according to Adams and coworkers criteria ( 56 ), oligo/amenorrhea Hyperprolactinemia, abnormal thyroid function tests

Open access

Kunal Thakkar, Swati Ramteke-Jadhav, Rajeev Kasaliwal, Saba Samad Memon, Virendra Patil, Puja Thadani, Nilesh Lomte, Shilpa Sankhe, Atul Goel, Sridhar Epari, Naina Goel, Anurag Lila, Nalini S Shah and Tushar Bandgar

hyperprolactinemia. Another patient (case 7) had headache, amenorrhoea, and clinical features of acromegaly. On hormonal evaluation, she had high IGF1 levels and mild hyperprolactinemia ( Table 1 ). In a recent extensive review including 69 patients with GCTs

Open access

T L C Wolters, C D C C van der Heijden, N van Leeuwen, B T P Hijmans-Kersten, M G Netea, J W A Smit, D H J Thijssen, A R M M Hermus, N P Riksen and R T Netea-Maier

insipidus 0 6 0.08  Hyperprolactinemia 0 1 0.63 Medical treatment 0 35 <0.001  SSA 0 30 <0.001  Dopamine agonist 0 6 0.08  Pegvisomant 0 8 0.03 Surgery 0 65 <0